title: Characteristics of synaptic transmission in reinnervating rat skeletal muscle.
abstract: Synaptic transmission, and its sensitivity to the effects of 3,4-diaminopyridine (3,4-DAP) and the phosphatase 2,3-butanedione monoxime (BDM), was examined for "crushed fiber" preparations of rat extensor digitorum longus muscle undergoing reinnervation after nerve crush. While mean quantal content (m) of endplate potentials (EPPs) was low early during reinnervation (10-24 days after nerve crush), elevation of temperature or extracellular calcium concentration restored m toward normal. However, m achieved control values for reinnervating preparations exposed to 3,4-DAP. 3,4-DAP also activated quiescent motor nerve terminals: after exposure to this drug, synaptic transmission was detected as early as 8 days after nerve crush. BDM too activated quiescent regenerating motor nerve terminals and increased m to normal. It also prolonged EPP and endplate current decay, suggesting a pre-synaptic effect on the synchrony of transmitter release and/or a post-synaptic effect on the open time of acetylcholine-gated endplate channels. While the effects of temperature, extracellular calcium, 3,4-DAP, and BDM suggest that regenerating nerve terminals can mobilise a reserve of quanta, this reserve is abnormally low, since hemicholinium-3 caused rapid rundown of EPP amplitude at repetitively stimulated regenerating endplates.
authors.affiliation: Department of Pharmacology and Toxicology, New Jersey Medical School (UMDNJ), Newark 07103-2757.
authors.forename: T M
authors.initials: TM
authors.lastname: Argentieri
authors.forename: S P
authors.initials: SP
authors.lastname: Aiken
authors.forename: S
authors.initials: S
authors.lastname: Laxminarayan
authors.forename: J J
authors.initials: JJ
authors.lastname: McArdle
mesh_terms: D015761:4-Aminopyridine / Q000031:analogs & derivatives / Q000494:pharmacology; D000077770:Amifampridine; D000818:Animals; D002118:Calcium / Q000502:physiology; D002801:Cholinesterase Reactivators / Q000494:pharmacology; D003931:Diacetyl / Q000031:analogs & derivatives / Q000494:pharmacology; D004594:Electrophysiology; D006426:Hemicholinium 3 / Q000494:pharmacology; D066298:In Vitro Techniques; D009045:Motor Endplate / Q000502:physiology; D009132:Muscles / Q000294:innervation / Q000502:physiology*; D009388:Neostigmine / Q000494:pharmacology; D009411:Nerve Endings / Q000502:physiology; D009416:Nerve Regeneration / Q000502:physiology; D015221:Potassium Channels / Q000187:drug effects; D051381:Rats; D011919:Rats, Inbred Strains; D013569:Synapses / Q000502:physiology*; D009435:Synaptic Transmission / Q000502:physiology*; D013696:Temperature
chemical_list: D002801:Cholinesterase Reactivators; D015221:Potassium Channels; C004717:diacetylmonoxime; D006426:Hemicholinium 3; D009388:Neostigmine; D015761:4-Aminopyridine; D003931:Diacetyl; D000077770:Amifampridine; D002118:Calcium